Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma developmentJared R. Mayers, Brian M. Wolpin, Chen Wu et al.|Nature Medicine|2014Cited by 664
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancerSrivatsan Raghavan, Alex K. Shalek, Peter Winter et al.|Cell|2021Cited by 586
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic CancerHarshabad Singh, Andrew J. Aguirre, Rachel B. Keller et al.|Clinical Cancer Research|2023Cited by 46
Sotorasib Is a Pan- <i>RAS</i> G12C Inhibitor Capable of Driving Clinical Response in <i>NRAS</i> G12C CancersDouglas A. Rubinson, Ryan B. Corcoran|Cancer Discovery|2024Cited by 40
Circulating Metabolites and Survival Among Patients With Pancreatic CancerChen Yuan, Brian M. Wolpin, Clary B. Clish et al.|JNCI Journal of the National Cancer Institute|2016Cited by 39